Recherche
-
Is There Any Room for Pharmacometrics With Immuno-Oncology Drugs? Input from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology
(Anticancer Research. vol. 39, n° 7, pp. 3419-3422, 2019-07-01)Article de revue -
Optimal Scheduling of Bevacizumab and Pemetrexed/cisplatin Dosing in Non‐Small Cell Lung Cancer
(CPT: Pharmacometrics and Systems Pharmacology, 2019-04-19)Article de revue -
Artificial Intelligence and Mechanistic Modeling for Clinical Decision Making in Oncology
(Clinical Pharmacology and Therapeutics, 2020-06-18)Article de revue -
Mechanistic modeling of metastasis: cancer at the organism scale
Communication dans un congrès -
Machine learning versus mechanistic modeling for prediction of metastatic relapse in breast cancer
Communication dans un congrès -
Data-driven mechanistic modeling of metastasis: cancer at the organism scale
Communication dans un congrès -
Combinatorial immunotherapy strategies : most gods throw dice, but fate plays chess
(Annals of Oncology, 2019-09-03)Article de revue -
Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer
(Scientific Reports. vol. 9, n° 1, 2019-09)Article de revue -
T2-based MRI Delta-Radiomics Improve Response Prediction in Soft-Tissue Sarcomas Treated by Neoadjuvant Chemotherapy
(Journal of Magnetic Resonance Imaging. vol. 50, n° 2, pp. 497-510, 2019-08)Article de revue -
Interval between planning and frameless stereotactic radiotherapy for brain metastases: are our margins still accurate?
(Neuro-Oncology Practice, 2019-10-01)Article de revue